C12Y 101/01239
3alpha-hydroxysteroid dehydrogenase , i.e. testosterone 17beta-dehydrogenase
Official title: 3Alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) (1.1.1.239), i.e. testosterone 17beta-dehydrogenase
C12Y101/01239 (3alpha-hydroxysteroid dehydrogenase , i.e. testosterone 17beta-dehydrogenase) appears on 1 US grants and 1 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 1
- Assignees
- 1
- Inventors
- 7
- Latest grant
- 25 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
By publication year.
Recent patents
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.